Ryan Carter

Ryan Carter is a Novo Nordisk Postdoctoral Research Fellow at the University of Oxford’s Institute of Developmental and Regenerative Medicine (IDRM). He specializes in the intersection of computational and molecular biology, particularly investigating metabolic diseases such as type II diabetes and cardiovascular disease. His work focuses on understanding how the Mexican Cavefish model’s unique immune investment strategy confers protection against metabolic disorders despite exhibiting diabetes-linked traits. Collaborating with the Choudhury group, he aims to translate these findings into clinical applications.

His research integrates evolutionary biology, genetics, and computational approaches to explore disease mechanisms, with a focus on translational potential. While no specific grants or awards are listed, his position as a Novo Nordisk fellow underscores institutional recognition of his work.